本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

72.11
+1.712.43%
盤前72.110.00000.00%05:55 EDT
成交量:46.44萬
成交額:3,323.92萬
市值:16.56億
市盈率:15.88
高:72.24
開:70.89
低:70.00
收:70.40
52周最高:99.39
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.54
換手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.77
市盈率(LYR):21.72

資料載入中...

2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities